Stay updated on BXCL701 in Pancreatic Cancer Clinical Trial
Sign up to get notified when there's something new on the BXCL701 in Pancreatic Cancer Clinical Trial page.

Latest updates to the BXCL701 in Pancreatic Cancer Clinical Trial page
- Check4 days agoChange DetectedCore trial information such as title, conditions, eligibility criteria, endpoints, and status remained unchanged; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check12 days agoNo Change Detected
- Check33 days agoChange Detected- Added a government funding lapse notice and current operating status guidance for NIH Clinical Center, and a version bump to v3.2.0. - Removed the previous version tag v3.1.0.SummaryDifference4%

- Check40 days agoChange Detected- Added PT-100 dipeptide and updated the revision to v3.1.0. - Removed talabostat and the older revision v3.0.2. Overall, the page updates reflect an updated product lineup and newer versioning, replacing the old item and version.SummaryDifference0.2%

- Check55 days agoChange DetectedUpdated to Revision: v3.0.2 (replacing v3.0.1); removed 'Back to Top'. This is a minor release update with no substantive changes to core content.SummaryDifference0.2%

- Check62 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes to core content or other important elements.SummaryDifference0.2%

- Check69 days agoChange DetectedThe web page has undergone significant updates, including the addition of a facility name and location, as well as new topics related to pancreatic cancer and cancer immunotherapy. However, several previous location details and resources have been removed.SummaryDifference2%

Stay in the know with updates to BXCL701 in Pancreatic Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the BXCL701 in Pancreatic Cancer Clinical Trial page.